Applied Therapeutics Receives FDA Complete Response Letter for Govorestat New Drug Application
Applied Therapeutics received a complete response letter from the FDA regarding their new drug application for govorestat due to clinical deficiencies. The stock dropped 16% in post-market trading. The company plans to review the feedback and potentially resubmit the NDA for the treatment of galactosemia.